Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)

Summary

The purpose of this study is to evaluate the effect of cysteamine in patients with symptomatic Huntington's disease by comparing two groups of patients (cysteamine vs placebo) on the results of the Unified Huntington's Disease Rating Scale (UHDRS, Huntington study group 1996).

Timeline

Start

2010-10

Primary completion

2015-07

Completion

—

Drugs

Indications